多重耐药细菌的抗生素选择(英文教学)Extending Our Options for Multi-drug Resistant Pathogens教程文件.pptVIP

下载本文档

4
0
约3.31万字
约 49页
2018-04-02 发布于天津
举报
版权申诉

多重耐药细菌的抗生素选择(英文教学)Extending Our Options for Multi-drug Resistant Pathogens教程文件.ppt

1、原创力文档（book118）网站文档一经付费（服务费），不意味着购买了该文档的版权，仅供个人/单位学习、研究之用，不得用于商业用途，未经授权，严禁复制、发行、汇编、翻译或者网络传播等，侵权必究。。
2、本站所有内容均由合作方或网友上传，本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺！文档内容仅供研究参考，付费前请自行鉴别。如您付费，意味着您自己接受本站规则且自行承担风险，本站不退款、不进行额外附加服务；查看《如何避免下载的几个坑》。如果您已付费下载过本站文档，您可以点击这里二次下载。
3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等，请点击“版权申诉”（推荐），也可以打举报电话：400-050-0827(电话支持时间：9:00-18:30)。
4、该文档为VIP文档，如果想要下载，成为VIP会员后，下载免费。
5、成为VIP后，下载本文档将扣除1次下载权益。下载后，不支持退款、换文档。如有疑问请联系我们。
6、成为VIP后，您将拥有八大权益，权益包括：VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
7、VIP文档为合作方或网友上传，每下载1次，网站将根据用户上传文档的质量评分、类型等，对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档

教学课件讲义PPT教学教案培训资料医学中小学上课资料

* * For 2008, HH Positive rate:7.19 StE positive rate:14.3 HH nosocomial rate2.91 STE nosocomial rate: 6.13 * Among the 655 patient with a clinically recognized infection, the hospital mortality rate from all causes was statistically greater for infection patients who received inadequate therapy compared to those who received adequate therapy (52.1% versus 23.5%, RR 2.22, CI 1.79 – 2.76). The infection related mortality rate was statistically greater among the inadequate therapy group compared to the patients who received adequate therapy (42% versus 17.1%, RR 2.37, CI 1.83 – 3.08). Multivariate analysis demonstrated that inadequate empiric therapy was the most important risk factor for hospital mortality. Other risk factors include multi-organ system failure, use of vasopressors, malignancy, increasing APACHE II score, and increasing age. * Surgical Site Infections due to MRSA have been shown to result in higher mortality than their MSSA counterparts. Researchers from Duke University evaluated the impact of methicillin resistance on SSI outcomes looking at patients following cardiothoracic, orthopedic, vascular, gynecological, and general surgery procedures with MRSA, MSSA infections and uninfected control patients. Mortality in the 90 day post-op period was significantly higher in patients with a MRSA infection. Almost 21% with an MRSA infection died compared to 7% with MSSA and 2% of uninfected patients. Costs were also significantly higher. The cost of treating an MRSA infection was almost $65,000 compared to $37,000 for MSSA and $21,000 for uninfected patients. * A study was performed in Chicago to measure the medical and societal cost attributable to antimicrobial resistant infection (ARI). Evaluated a random sample of hospitalized patients from the year 2000. Patients with trauma, burns, and OB patients excluded. Medical costs were from the hospital prospective and included length of stay, lab and radiology tests, procedures, treatments (dr